Full-Time
Accounts Receivable Accountant
Updated on 9/4/2026
Redcare Pharmacy
51-200 employees
Online pharmacy selling prescription meds
No salary listed
Cologne, Germany
In Person
 Accounting (1) |
|---|
Get referred to Redcare Pharmacy
See people who can refer or advise you
- Professional experience in accounts receivable accounting with a solid understanding of B2B and B2C financial processes in an international environment.
- Strong communication skills and the ability to build effective relationships with different stakeholders.
- High technical affinity and confident use of finance and accounting systems.
- Very good German and English language skills, both written and spoken.
- Ensure the correct and timely processing of customer invoices, proactively communicate with customers about transactions, manage payment delays, and process credit notes to clarify accounts.
- Monitor and collect overdue receivables with the goal of minimizing Days Sales Outstanding, communicate with debtors about outstanding invoices in writing and by telephone, and coordinate with collection agencies when needed.
- Work closely with internal teams including Customer Service, E-Payments, Accounts Payable, Information Technology, and Enterprise Resource Planning to optimize accounting processes.
- Perform account reconciliations, process open items, and carefully maintain and manage customer payment information.
- Decide on payment deferrals, process credit notes, and validate receivables as part of accounting reviews.
Redcare Pharmacy runs an online European pharmacy that sells prescription and over-the-counter medicines, health supplements, and beauty/personal care items directly to customers. It uses a web-based e-commerce platform, bypassing physical pharmacies, and has integrated digital health tools (such as MyTherapy and Dutch e-health platforms) and electronic prescriptions to streamline ordering and medication management. The company differentiates itself by expanding through acquisitions (e.g., Europa Apotheek, nu3) to grow prescription drug sales and digital health offerings, while focusing on the DACH region and maintaining a catalog of 150,000+ products. Its goal is to provide convenient, affordable access to medicines and health products across Europe via a scalable online platform.
Company Size
51-200
Company Stage
IPO
Headquarters
Venlo, Netherlands
Founded
2001
Get referred to Redcare Pharmacy
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue rose 20%, and Germany Rx revenue surged 58%.
- Adjusted EBITDA margin hit 3.5% in Q2 2026, the highest level in a decade.
- Full-year 2026 guidance rose to 15-17% growth, signaling sustained demand momentum.
What critics are saying
- Rossmann’s online pharmacy launch in 2026 targets Redcare’s OTC traffic and margins.
- July 2026 trading weakened, and management expects Rx growth to slow in H2 2026.
- Redcare was not cash flow positive in Q2 2026, risking funding pressure if growth stalls.
What makes Redcare Pharmacy unique
- Redcare dominates German e-prescriptions, reaching 1.7 million active Rx customers by June 2026.
- Its 14.7 million active customers create unmatched European pharmacy scale and repeat-purchase data.
- International operations reached break-even in Q2 2026, proving cross-border model portability.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Paid Vacation
Employee Discount
Training Programs
Commuter Benefits
Employee Referral Bonus
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↓ -1%2 year growth
↑ 0%Redcare Pharmacy NV raised its 2026 revenue growth guidance to 15-17%, up from the previous 13-15%. The online pharmacy reported reaching 1.7 million active prescription customers in Germany, representing 4% quarter-over-quarter growth. The company's adjusted EBITDA margin improved to 3.5% in Q2, its highest level in a decade. This was achieved whilst reducing marketing spending, demonstrating improved cost efficiency. However, the German non-prescription business experienced growth deceleration, partly attributed to a heatwave and competitive pressures. July trading was softer than expected, with anticipated group growth below 20%. CEO Olaf Heinrich addressed concerns about competitor Rossmann entering the online pharmacy market, noting that previous entrant DM had limited impact. He emphasised the complexity of the prescription segment as a barrier to new competitors. A new regulation requiring personal signatures for prescription deliveries will add minimal costs, expected to be less than £1 million annually. The company was not cash flow positive in Q2 despite improved profitability.
Redcare Pharmacy N.V. / Key word(s): Bond Redcare Pharmacy: Redemption of 2021/2028 convertible bond. 19.12.2025 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement.
Redcare Pharmacy has announced that bondholders will redeem €64.5 million of its convertible bonds on 21 January 2026. Following this transaction, the remaining nominal amount of the 2021/2028 convertible bond will be €2.6 million.
SHOP APOTHEKE EUROPE will acquire 51% of the shares of Mediservice AG, while Galenica AG will hold 49% of the joint venture.
The Supervisory Board of SHOP APOTHEKE EUROPE has appointed Olaf Heinrich as new CEO as of 1 August 2023, subject to approval by the AGM.